MediWound
MDWD
19 hedge funds and large institutions have $11M invested in MediWound in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 12 closing their positions.
10.95% more ownership
Funds ownership: 3.07% → 14.02% (+11%)
9% less capital invested
Capital invested by funds: $12.1M → $11M (-$1.1M)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
32% less funds holding
Funds holding: 28 → 19 (-9)
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $438K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$342K |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$132K |
| 3 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$101K |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$42.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$29.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$2.66M |
| 2 |
ACM
Altium Capital Management
New York
|
-$1.57M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$233K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$113K |
| 5 |
Millennium Management
New York
|
-$57K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
LPL Financial
San Diego,
California
| – | -$18K | -1,880 | Closed |
|
|
MA
27
MUFG Americas
New York
| – | -$2K | -229 | Closed |
|
|
GWM
28
Geneos Wealth Management
Englewood,
Colorado
| – | -$2K | -214 | Closed |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$729 | -72 | -91% |
|
30
JP Morgan Chase
New York
| – | +$20 | +2 | New |
|
MDWD Hedge Fund Activity: Q4 2022 in Review
19 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in MediWound (MDWD) for Q4 2022, worth a combined $11M — down 9.1% from $12.1M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of MDWD and 3 opened new positions — a net loss of 9 holders — while 8 trimmed existing stakes and 6 added.
The largest buyer was Meitav Investment House, adding an estimated $342K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.66M sold.
- 19 institutional investors held MediWound (MDWD) as of Q4 2022, down from 28 in Q3 2022.
- Funds reported $11M of MediWound stock for Q4 2022, down 9.1% quarter-over-quarter.
- 3 funds opened new MediWound positions in Q4 2022 and 12 closed out, a net change of -9 holders.
- The largest MediWound buyer in Q4 2022 was Meitav Investment House, an estimated $342K added.
- The largest MediWound seller in Q4 2022 was Armistice Capital, an estimated $2.66M sold.
Based on aggregated 13F filings for Q4 2022.